This inventor holds 1 USPTO granted patent. Top assignee: Glaxosmithkline LLC. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012
Title: Vincente Samano: Innovator in Metabolic Disorder Treatments
Introduction
Vincente Samano is a notable inventor based in Durham, NC (US). He has made significant contributions to the field of medical science, particularly in the treatment of metabolic disorders. His work focuses on developing novel chemical compounds that can aid in managing conditions such as Type II diabetes mellitus.
Latest Patents
Vincente Samano holds 1 patent related to chemical compounds. This patent pertains to innovative compounds that are useful in the treatment of metabolic disorders, specifically targeting Type II diabetes mellitus and related conditions. The invention also encompasses methods for the making and use of these compounds, showcasing his commitment to advancing medical treatments.
Career Highlights
Vincente is currently employed at GlaxoSmithKline LLC, a leading global healthcare company. His role involves research and development aimed at creating effective solutions for metabolic disorders. His expertise and dedication have positioned him as a valuable asset in the pharmaceutical industry.
Collaborations
Throughout his career, Vincente has collaborated with esteemed colleagues, including Subba Reddy Katamreddy and Richard Dama Caldwell. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.
Conclusion
Vincente Samano's contributions to the field of metabolic disorder treatments highlight his innovative spirit and dedication to improving healthcare. His work continues to inspire advancements in medical science and offers hope for those affected by metabolic disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
